Fig. 6

COX regression analysis of OS of LGG, LUAD, and SKCM patients in TCGA and validation in GEO and CGGA. Univariate (left) and multivariate (right) COX regression analysis of OS in LGG (A), LUAD (B), and SKCM (C) patients from TCGA. D Differences in TASL mRNA expression between tumor and normal tissues for 20 cancer types in GEO. (E) K-M curves for OS or DSS of LGG, LUAD, and SKCM patients grouped by high and low TASL expression from CGGA or GEO database. F Correlation of TASL expression with different WHO grades or pathological stages of LGG, LUAD, and SKCM (*P < 0.05; **P < 0.01; ***P < 0.001)